The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

Cannabis and cocaine are the most commonly used drugs in the EU, but several others pose a threat to public health. View on ...

Fewer than half of heart patients from 17 countries who could benefit from beneficial drugs are taking them, researchers ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Uncontrolled blood glucose (sugar) can lead to complications that may include cardiovascular disease, high blood pressure, nerve and eye damage, and kidney disease. Now, an analysis of studies has ...